您搜索了: instigating the conduct in question (希腊语 - 英语)

the conduct of bioequivalence studies for
the conduct of bioequivalence studies for veterinary medicinal products released for consultation january 2000

note for guidance on the conduct of pharmacovigilance for centrally authorised products
note for guidance on the conduct of pharmacovigilance for centrally authorised products

to consent to a change in the respective ranking of charges over the real estate in question and to grant preferential rights between beneficiaries as shall be deemed appropriate;
to consent to a change in the respective ranking of charges over the real estate in question and to grant preferential rights between beneficiaries as shall be deemed appropriate

Στο βιβλίο μου «the school in question» ασχολήθηκα μ' αυτήν, καθώς και με άλλες αντιφάσεις (husen, 1979).
in addition, everybody in the present and the future society needs to become 'literate' in science.

depending on the area in question, the letter “a” may mean that the use of pitons (or other gear that requires the use of a hammer) is needed to ascend the route.
depending on the area in question, the letter “a” may mean that the use of pitons (or other gear that requires the use of a hammer) is needed to ascend the route.

Τίτλος εγγράφου revision of note for guidance on the conduct of pharmacovigilance for centrally authorised products revision of crisis management plan regarding centrally authorised products for human use guidance document for the implementation of the position paper on compliance with pharmacovigilance regulatory obligations contribution to note for guidance on the use of medicinal products during pregnancy:
document title revision of note for guidance on the conduct of pharmacovigilance for centrally authorised products revision of crisis management plan regarding centrally authorised products for human use guidance document for the implementation of the position paper on compliance with pharmacovigilance regulatory obligations contribution to note for guidance on the use of medicinal products during pregnancy:

in cases of ordinary negligence , the ecb 's liability shall be limited to the participant 's direct loss , i.e. the amount of the transaction in question and / or the loss of interest thereon , excluding any consequential loss .
in cases of ordinary negligence , the ecb 's liability shall be limited to the participant 's direct loss , i.e. the amount of the transaction in question and / or the loss of interest thereon , excluding any consequential loss .

choice of control group in clinical trials (cpmp/ ich/ 364/ 96), ich e10 clinical investigation of medicinal products in children (cpmp/ ich/ 2711/ 99), ich e11 safety pharmacology studies for human pharmaceuticals (cpmp/ ich/ 539/ 00), ich s7a stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ ich/ 2736/ 99 rev. of cpmp/ ich/ 380/ 95), ich q1ar non- clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ ich/ 286/ 95, modification), ich m3 modification reproductive toxicology: toxicity to male fertility (cpmp/ ich/ 136/ 95 modification), ich s5b modification data elements for transmission of individual case safety reports (cpmp/ ich/ 287/ 95 modification), ich e2b recommendations on electronic transmission of individual case safety reports message specification (cpmp/ ich/ 285/ 95), ich m2 good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ ich/ 4106/ 00), ich q7a common technical document (ctd), (cpmp/ ich/ 2887/ 99), ich m4
final guidelines • choice of control group in clinical trials (cpmp/ ich/ 364/ 96), ich e10 • clinical investigation of medicinal products in children (cpmp/ ich/ 2711/ 99), ich e11 • safety pharmacology studies for human pharmaceuticals (cpmp/ ich/ 539/ 00), ich s7a • stability testing guidelines: stability testing of new active substances and medicinal products (cpmp/ ich/ 2736/ 99 rev. of cpmp/ ich/ 380/ 95), ich q1ar • non-clinical safety studies for the conduct of human clinical trials for pharmaceuticals (cpmp/ ich/ 286/ 95, modification), ich m3 modification • reproductive toxicology: toxicity to male fertility (cpmp/ ich/ 136/ 95 modification), ich s5b modification • data elements for transmission of individual case safety reports (cpmp/ ich/ 287/ 95 modification), ich e2b • recommendations on electronic transmission of individual case safety reports message specification (cpmp/ ich/ 285/ 95), ich m2 • good manufacturing practice guide for active pharmaceutical ingredients (cpmp/ ich/ 4106/ 00), ich q7a • common technical document (ctd), (cpmp/ ich/ 2887/ 99), ich m4